Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Accumulated Expenses: 2011-2024

Historic Accumulated Expenses for Capricor Therapeutics (CAPR) over the last 7 years, with Dec 2024 value amounting to $4.9 million.

  • Capricor Therapeutics' Accumulated Expenses was N/A to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year change of. This contributed to the annual value of $4.9 million for FY2024, which is N/A change from last year.
  • As of FY2024, Capricor Therapeutics' Accumulated Expenses stood at $4.9 million, which was up 477.73% from $849,469 recorded in FY2016.
  • In the past 5 years, Capricor Therapeutics' Accumulated Expenses ranged from a high of $4.9 million in FY2024 and a low of $4.9 million during FY2024.
  • Over the past 1 years, Capricor Therapeutics' median Accumulated Expenses value was $4.9 million (recorded in 2024), while the average stood at $4.9 million.